Neuphoria Therapeutics Inc/$NEUP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Neuphoria Therapeutics Inc
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
Ticker
$NEUP
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
-
ISIN
US64136E1029
Website
NEUP Metrics
BasicAdvanced
$11M
3673.35
$0.00
-
-
Price and volume
Market cap
$11M
52-week high
$6.23
52-week low
$4.33
Average daily volume
16K
Financial strength
Current ratio
11.011
Quick ratio
10.998
Long term debt to equity
0.074
Total debt to equity
0.543
Management effectiveness
Return on assets (TTM)
-1.01%
Return on equity (TTM)
26.80%
Valuation
Price to earnings (TTM)
3,673.349
Price to revenue (TTM)
715.27
Price to book
0.44
Price to tangible book (TTM)
0.92
Price to free cash flow (TTM)
17,209.945
Growth
Revenue change (TTM)
-35,282.09%
Earnings per share change (TTM)
-103.73%
3-year revenue growth (CAGR)
97.22%
3-year earnings per share growth (CAGR)
-46.44%
NEUP News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Neuphoria Therapeutics Inc stock?
Neuphoria Therapeutics Inc (NEUP) has a market cap of $11M as of May 23, 2025.
What is the P/E ratio for Neuphoria Therapeutics Inc stock?
The price to earnings (P/E) ratio for Neuphoria Therapeutics Inc (NEUP) stock is 3673.35 as of May 23, 2025.
Does Neuphoria Therapeutics Inc stock pay dividends?
No, Neuphoria Therapeutics Inc (NEUP) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next Neuphoria Therapeutics Inc dividend payment date?
Neuphoria Therapeutics Inc (NEUP) stock does not pay dividends to its shareholders.
What is the beta indicator for Neuphoria Therapeutics Inc?
Neuphoria Therapeutics Inc (NEUP) does not currently have a Beta indicator.